How has COVID-19 impacted the business?
During 2020, SGD Pharma continued its daily operations and even improved performance in all plants, strengthened clients’ trust and gained market shares, accelerated R&D capabilities, and recruited and improved training efforts. Our plants in Asia and Europe are all subject to the highest level of safety measures to ensure the health and safety of employees while continuing manufacturing operations.